For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) closed at $1042.69 up 0.26% from its previous closing price of $1039.96. In other words, the price has increased by $0.26 from its previous closing price. On the day, 0.66 million shares were traded. REGN stock price reached its highest trading level at $1070.0 during the session, while it also had its lowest trading level at $1036.8801.
Ratios:
For a deeper understanding of Regeneron Pharmaceuticals, Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 34.53. For the most recent quarter (mrq), Quick Ratio is recorded 4.62 and its Current Ratio is at 5.44. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on September 24, 2024, Downgraded its rating to Market Perform and sets its target price to $1077 from $1175 previously.
On March 12, 2024, Bernstein started tracking the stock assigning a Outperform rating and target price of $1125.
RBC Capital Mkts Upgraded its Sector Perform to Outperform on January 12, 2024, whereas the target price for the stock was revised from $884 to $1076.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 03 ’24 when McCourt Marion sold 1,000 shares for $1178.73 per share. The transaction valued at 1,178,730 led to the insider holds 12,931 shares of the business.
RYAN ARTHUR F sold 100 shares of REGN for $117,868 on Sep 03 ’24. The Director now owns 17,682 shares after completing the transaction at $1178.68 per share. On Sep 03 ’24, another insider, MARION E MCCOURT, who serves as the Officer of the company, bought 1,000 shares for $1178.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REGN now has a Market Capitalization of 114865971200 and an Enterprise Value of 105436856320. As of this moment, Regeneron’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.61, and their Forward P/E ratio for the next fiscal year is 21.43. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.52 while its Price-to-Book (P/B) ratio in mrq is 4.07. Its current Enterprise Value per Revenue stands at 7.816 whereas that against EBITDA is 23.331.
Stock Price History:
Over the past 52 weeks, REGN has reached a high of $1211.20, while it has fallen to a 52-week low of $769.19. The 50-Day Moving Average of the stock is -7.48%, while the 200-Day Moving Average is calculated to be 4.14%.
Shares Statistics:
For the past three months, REGN has traded an average of 494.59K shares per day and 775220 over the past ten days. A total of 107.60M shares are outstanding, with a floating share count of 106.30M. Insiders hold about 3.55% of the company’s shares, while institutions hold 86.57% stake in the company. Shares short for REGN as of 1726185600 were 1976159 with a Short Ratio of 4.00, compared to 1723680000 on 2110709. Therefore, it implies a Short% of Shares Outstanding of 1976159 and a Short% of Float of 1.8900000000000001.
